Daniel Mulligan

The Ohio State University Wexner Medical Center

Papers

Total Citations

H-Index

About

Daniel Mulligan is a pioneering urologic surgeon and researcher whose work has fundamentally advanced the field of minimally invasive kidney surgery. His primary research focus is on optimizing surgical outcomes for renal cell carcinoma, with a particular emphasis on reducing the morbidity associated with traditional partial nephrectomy. Mulligan's most notable contribution is his landmark 2012 study, "Robotic Partial Nephrectomy Without Renal Ischemia," which demonstrated the feasibility of performing complex tumor resections without clamping the renal artery. This technique, which has garnered 44 citations, challenged the long-standing dogma that temporary renal ischemia was necessary for a bloodless surgical field, offering a potential pathway to preserve maximum kidney function. Beyond this seminal work, Mulligan has been instrumental in developing and refining robotic surgical protocols, training a generation of surgeons in these advanced techniques. His research has directly influenced clinical practice, helping to shift the standard of care toward more nephron-sparing approaches. With a career dedicated to translating surgical innovation into tangible patient benefits, Mulligan stands as a key figure in the evolution of robotic urologic oncology.